Press Release: Covista Announces Third Quarter Fiscal Year 2026 Conference Call

Dow Jones
04/07
CHICAGO--(BUSINESS WIRE)--April 07, 2026-- 

Covista (the "company" or "Covista") $(CVSA)$, the largest healthcare educator in the United States, announced today it will release its third quarter fiscal year 2026 results on Thursday, May 7, 2026, after market close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results.

This call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Covista earnings call" or by using conference ID: 13759299. The call will be simulcast through the Covista investor relations website at: https://investors.covista.com. Covista will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13759299, or visit the Covista investor relations website.

About Covista

Covista is America's largest healthcare educator, serving more than 97,000 students and supported by a community of 385,000 alumni across five accredited institutions. Through personalized, tech-enabled education powered by 10,000 faculty and colleagues, Covista expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale. Covista is the parent company of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. For more information, visit covista.com and follow us on LinkedIn, Instagram and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260407534052/en/

 
    CONTACT:    Investor Contact: Jeremy Cohen, Investor.Relations@covista.com 

Media Contact: Maureen Bender, covistamedia@covista.com

 
 

(END) Dow Jones Newswires

April 07, 2026 08:03 ET (12:03 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10